CASS Pharmaceuticals, Inc. — Form D
CASS Pharmaceuticals, Inc. of FRANKLIN, TN, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-21. The offering totals $4.5M, of which $2.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2022-10-21
- Form: D
- Accession: 0001822787-22-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $4.5M
- Amount sold: $2.0M
- Remaining: $2.5M
- Investors: 6
- Date of first sale: 2022-08-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-462497
Issuer
- Name: CASS Pharmaceuticals, Inc.
- CIK: 0001822787
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1465 WILLOWBROOKE CIRCLE, FRANKLIN, TN, 37069
- Phone: (914) 329-3112
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Stephen McCormack | Director | FRANKLIN, TN |
| Solomon Steiner | Director | Danbury, CT |
| Stephen McCormack | Executive Officer | FRANKLIN, TN |
| Solomon Steiner | Executive Officer | Danbury, CT |
| Stephen McCormack | Promoter | FRANKLIN, TN |
| Solomon Steiner | Promoter | Danbury, CT |
Other filings by this issuer (1)
More